---
figid: PMC4329471__zh50021566670002
figlink: /pmc/articles/PMC4329471/figure/F2/
number: F2
caption: Vasoconstriction and vasodilation pathways and therapies for pulmonary hypertension
  (PH). Activation of soluble guanylate cyclase (sGC) by nitric oxide (NO) increases
  cyclic guanosine monophosphate (cGMP) levels and leads to vasodilation and inhibition
  of cellular proliferation in smooth muscle cells (SMC) through the activation of
  sGC by NO. Inhaled NO, oral nitrite and nitrate, oral l-arginine or tetrahydrobiopterin
  (BH4), and phosphodiesterase 5 (PDE5) inhibitors (sildenafil/tadalafil) modulate
  PH through the NO-sGC-cGMP pathway. Prostacyclins, produced from arachidonic acid
  by cyclooxygenase (COX) in endothelial cells, target the prostanoid receptor (IP)
  on smooth muscle cells leading to the activation of adenylate cyclase, which forms
  cyclic adenosine monophosphate (cAMP) from adenosine triphosphate (ATP). cAMP promotes
  vasodilation and inhibits cellular proliferation in SMC. Epoprostenol is a prostanoid
  derivative and selexipag is a new IP receptor agonist that can treat PH through
  the prostacyclin pathway. Endothelin-1 (ET-1) promotes vasoconstriction and vascular
  remodeling through binding to ET-A and -B receptors of the SMC. Ambrisentan binds
  to ET-A and bosentan binds to both ET-A and B. Both ET-1 blockers have been used
  to treat PH in the endothelin pathway.
pmcid: PMC4329471
papertitle: Vasculopathy and pulmonary hypertension in sickle cell disease.
reftext: Karin P. Potoka, et al. Am J Physiol Lung Cell Mol Physiol. 2015 Feb 15;308(4):L314-L324.
pmc_ranked_result_index: '152926'
pathway_score: 0.932711
filename: zh50021566670002.jpg
figtitle: Vasoconstriction and vasodilation pathways and therapies for pulmonary hypertension
  (PH)
year: '2015'
organisms: Homo sapiens
ndex: 141744e7-defe-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4329471__zh50021566670002.html
  '@type': Dataset
  description: Vasoconstriction and vasodilation pathways and therapies for pulmonary
    hypertension (PH). Activation of soluble guanylate cyclase (sGC) by nitric oxide
    (NO) increases cyclic guanosine monophosphate (cGMP) levels and leads to vasodilation
    and inhibition of cellular proliferation in smooth muscle cells (SMC) through
    the activation of sGC by NO. Inhaled NO, oral nitrite and nitrate, oral l-arginine
    or tetrahydrobiopterin (BH4), and phosphodiesterase 5 (PDE5) inhibitors (sildenafil/tadalafil)
    modulate PH through the NO-sGC-cGMP pathway. Prostacyclins, produced from arachidonic
    acid by cyclooxygenase (COX) in endothelial cells, target the prostanoid receptor
    (IP) on smooth muscle cells leading to the activation of adenylate cyclase, which
    forms cyclic adenosine monophosphate (cAMP) from adenosine triphosphate (ATP).
    cAMP promotes vasodilation and inhibits cellular proliferation in SMC. Epoprostenol
    is a prostanoid derivative and selexipag is a new IP receptor agonist that can
    treat PH through the prostacyclin pathway. Endothelin-1 (ET-1) promotes vasoconstriction
    and vascular remodeling through binding to ET-A and -B receptors of the SMC. Ambrisentan
    binds to ET-A and bosentan binds to both ET-A and B. Both ET-1 blockers have been
    used to treat PH in the endothelin pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - COX7B2
  - COX17
  - ADCY1
  - ADCY10
  - COX5A
  - ADCY8
  - ADCY9
  - ADCY4
  - COX10
  - COX6B2
  - COX15
  - COX4I1
  - COX5B
  - ADCY7
  - ARHGEF12
  - ADCY2
  - ADCY3
  - COX4I2
  - ADCY6
  - COX7A2
  - COX7B
  - COX6B1
  - COX11
  - COX6A1
  - COX8C
  - ADCY5
  - COX7A1
  - COX6A2
  - COX8A
  - SON
  - SGCB
  - L-Arginine
  - Arg
  - Nitrite
  - PGE
  - Epoprostenol
  - Prostacyclin
genes:
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7B2
  entrez: '170712'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX17
  entrez: '10063'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX5A
  entrez: '9377'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX10
  entrez: '1352'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6B2
  entrez: '125965'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX15
  entrez: '1355'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX4I1
  entrez: '1327'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX5B
  entrez: '1329'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: -L-Arg
  symbol: LARG
  source: hgnc_alias_symbol
  hgnc_symbol: ARHGEF12
  entrez: '23365'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX4I2
  entrez: '84701'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7A2
  entrez: '1347'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7B
  entrez: '1349'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6B1
  entrez: '1340'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX11
  entrez: '1353'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6A1
  entrez: '1337'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX8C
  entrez: '341947'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7A1
  entrez: '1346'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6A2
  entrez: '1339'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX8A
  entrez: '1351'
- word: SON
  symbol: SON
  source: hgnc_symbol
  hgnc_symbol: SON
  entrez: '6651'
- word: SGC
  symbol: SGC
  source: hgnc_alias_symbol
  hgnc_symbol: SGCB
  entrez: '6443'
chemicals:
- word: L-Arginine
  source: MESH
  identifier: D001120
- word: Arg
  source: MESH
  identifier: D001120
- word: Nitrite
  source: MESH
  identifier: D009573
- word: PGE
  source: MESH
  identifier: D011458
- word: Epoprostenol
  source: MESH
  identifier: D011464
- word: Prostacyclin
  source: MESH
  identifier: D011464
diseases: []
figid_alias: PMC4329471__F2
redirect_from: /figures/PMC4329471__F2
figtype: Figure
---
